RVMD compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

RVMDRevolution Medicines, Inc.

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RVMDRevolution Medicines, Inc.

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RVMD2 of 4 reports

1 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.7%▼−11.04%×1.13

Q2 FY26±7.9%▲+0.26%×0.04

TNGX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.4%▼−4.81%×0.42

May 14 '26±14.3%▼−2.51%×0.17

= impliedRVMD realized, solidTNGX realized, hatchedOne scale, both sides: full bar = 43%× = |realized| ÷ impliedspan: RVMD 91d · TNGX 215dSource: market data

Q1 FY26

±42.5%

▲+36.28%

×0.85

Jan 8 '26±30.3%▼−6.23%×0.20

RVMDRevolution Medicines, Inc.

192.54▲+8.38%· post 193.00

Mkt cap$41.6BRevenue$198MQ3 FY26Revenue—

TNGXTango Therapeutics, Inc.

21.49▲+2.96%· post 21.49

ClosedNov 6 '26

Mkt cap$3.6BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

ClosedNov 6 '26

RVMDRevolution Medicines, Inc.

TNGXTango Therapeutics, Inc.

192.54▲+8.38%post 193.00

Price

21.49▲+2.96%post 21.49

$41.6B

Mkt cap

$3.6B

Q3 FY26$198M

Revenue

$54MQ3 FY25

—

Revenue

$42MFY24

RVMD192.54▲+8.38%vsTNGX21.49▲+2.96%ClosedNov 6 '26